GOCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Gohealth Inc (GOCO) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is facing severe financial challenges, with significant declines in revenue, net income, and EPS. Additionally, there are no positive trading signals, no recent news catalysts, and no strong technical indicators suggesting a reversal or growth potential. The lack of insider or hedge fund activity further supports a cautious approach. Given the user's impatience and unwillingness to wait for optimal entry points, this stock is not suitable for investment at this time.
The MACD is slightly positive but contracting, indicating weak momentum. RSI is neutral at 45.953, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level (1.794), with key support at 1.433 and resistance at 2.155. Overall, the technical indicators do not suggest a strong buying opportunity.
NULL identified. No recent news or significant trading trends from insiders or hedge funds.
Severe financial deterioration in Q3 2025, with revenue down 71.10% YoY, net income down 2950.91% YoY, and EPS down 2665.22% YoY. Gross margin is also negative at -27.56%. The stock has also dropped 8.94% in regular market trading.
In Q3 2025, the company reported a significant decline in financial performance: Revenue dropped to $34.19M (-71.10% YoY), Net Income dropped to -$166.83M (-2950.91% YoY), EPS dropped to -11.8 (-2665.22% YoY), and Gross Margin dropped to -27.56% (-143.42% YoY).
No recent analyst rating or price target changes available.
